149 related articles for article (PubMed ID: 10938961)
1. Emerging viruses in blood transfusion.
Allain JP
Vox Sang; 2000; 78 Suppl 2():243-8. PubMed ID: 10938961
[TBL] [Abstract][Full Text] [Related]
2. Emerging viral infections relevant to transfusion medicine.
Allain JP
Blood Rev; 2000 Dec; 14(4):173-81. PubMed ID: 11124105
[TBL] [Abstract][Full Text] [Related]
3. The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.
Kleinman SH; Glynn SA; Higgins MJ; Triulzi DJ; Smith JW; Nass CC; Garratty G; Murphy EL; LeParc GF; Schreiber GB; King MR; Chamberland ME; Nemo GJ
Transfusion; 2005 Jul; 45(7):1073-83. PubMed ID: 15987350
[TBL] [Abstract][Full Text] [Related]
4. Emerging viruses and transfusion.
Allain JP
Transfus Clin Biol; 2001 Jun; 8(3):220-1. PubMed ID: 11499963
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-transmitted virus prevalence in Turkish patients with thalassemia.
Ozyürek E; Ergünay K; Kuskonmaz B; Unal S; Cetin M; Ustaçelebi S; Gürgey A; Gümrük F
Pediatr Hematol Oncol; 2006 Jun; 23(4):347-53. PubMed ID: 16621777
[TBL] [Abstract][Full Text] [Related]
6. Blood-borne viral infections.
Gürtler L
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 3():S5-10; discussion S11-2. PubMed ID: 7749048
[TBL] [Abstract][Full Text] [Related]
7. SEN virus infection and its relationship to transfusion-associated hepatitis.
Umemura T; Yeo AE; Sottini A; Moratto D; Tanaka Y; Wang RY; Shih JW; Donahue P; Primi D; Alter HJ
Hepatology; 2001 May; 33(5):1303-11. PubMed ID: 11343260
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid testing for emerging viral infections.
Allain JP; Thomas I; Sauleda S
Transfus Med; 2002 Aug; 12(4):275-83. PubMed ID: 12220257
[TBL] [Abstract][Full Text] [Related]
9. Transfusion-transmitted infectious diseases.
Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prevalence rates of microbiological markers between bone/tissue donations and new blood donors in Scotland.
Galea G; Dow BC
Vox Sang; 2006 Jul; 91(1):28-33. PubMed ID: 16756598
[TBL] [Abstract][Full Text] [Related]
11. SEN virus infection does not affect the progression of non-A to -E liver disease.
Mikuni M; Moriyama M; Tanaka N; Abe K; Arakawa Y
J Med Virol; 2002 Aug; 67(4):624-9. PubMed ID: 12116015
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and genotypic distribution of hepatitis GB-C/HG and TT viruses in blood donors, mentally retarded children and four groups of patients in eastern Anatolia, Turkey.
Kalkan A; Ozdarendeli A; Bulut Y; Saral Y; Ozden M; Keleştimur N; Toraman ZA
Jpn J Infect Dis; 2005 Aug; 58(4):222-7. PubMed ID: 16116255
[TBL] [Abstract][Full Text] [Related]
13. SEN virus: epidemiology and characteristics of a transfusion-transmitted virus.
Akiba J; Umemura T; Alter HJ; Kojiro M; Tabor E
Transfusion; 2005 Jul; 45(7):1084-8. PubMed ID: 15987351
[TBL] [Abstract][Full Text] [Related]
14. SEN virus infection.
Sagir A; Kirschberg O; Heintges T; Erhardt A; Häussinger D
Rev Med Virol; 2004; 14(3):141-8. PubMed ID: 15124231
[TBL] [Abstract][Full Text] [Related]
15. SEN virus infection--a new hepatitis virus: a review.
Sehgal R
Indian J Pathol Microbiol; 2003 Apr; 46(2):253-5. PubMed ID: 15022932
[TBL] [Abstract][Full Text] [Related]
16. [GBV-C/HGV and TTV infection markers in Polish blood donors and haemophilia patients].
Grabarczyk P; Brojer E; Windyga J; łopaciuk S; Klukowska A; Mikulska M
Przegl Epidemiol; 2006; 60(3):581-8. PubMed ID: 17249183
[TBL] [Abstract][Full Text] [Related]
17. Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors.
Wang B; Higgins MJ; Kleinman S; Schreiber GB; Murphy EL; Glynn SA; Wright DJ; Nass CC; Chang D; Busch MP;
Transfusion; 2004 Aug; 44(8):1243-51. PubMed ID: 15265131
[TBL] [Abstract][Full Text] [Related]
18. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
Corash L
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
[TBL] [Abstract][Full Text] [Related]
19. Beyond HIV, HBV and HCV--how to deal with other viruses?
Minor PD
Dev Biol (Basel); 2002; 108():15-9. PubMed ID: 12220138
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B, hepatitis C, GB virus C/hepatitis G and TT viruses in predialysis and hemodialysis patients.
López-Alcorocho JM; Barril G; Ortiz-Movilla N; Traver JA; Bartolomé J; Sanz P; Selgas R; Carreño V
J Med Virol; 2001 Feb; 63(2):103-7. PubMed ID: 11170045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
